)&,+$*.20/-1 3 (%'*&, "#!    2018 610 #/?87-,2@"@$7;=
8' /87-,20>92%!3+=*
1.16/<@ 6584/)1&/(6 : ,*LS^~Papanicolaoul1942|3V9yhPapanicolau9EXrR1943|fDCy@
LS ru}lyhgy~1971}LS^,1}y*GD}LS^5^<~92z` xigzpl T~\ F|H[ym>4}c&Kln+bLS^}%Z'lA[qupz|
TLS^}0 laugrkr TD6<l$rOoxi;8d2000 #rx Tl4^leq TLS^}&?zt})2l qxmxi
gt}uY}{i TLS^}(QlrxigIuv~"J|jo TLS^.WC|wix
U ^-zLS^jB=MP^-N2z7_4]ru}y sg
LS^ 2015!: /1ULS

20131(201712'"%-)& $#+*. ,  !172

14

27

40

77

1930



00-

10-

20-

30-

40-



50-



60-

70-

80-

71
101

61

26

20
10

4

30

49

3990-

67.2

"!
!

" Squamous cell
hyperplasia

+,(%10   . /

2005 WHOClassification
WHO dysplasiagrade).Liquid based cytology, LBC/Squamousintraepithelialneoplasia

2015 JSCC
Pap. Classification
guideline

Indefinite for neoplasia

Mild dysplasia

SIN1

Moderate dysplasia

SIN2(Severe dysplasia)(CIS; JSOP)

SIN3

Carcinoma in situ

SIN3**)'-&!$#PAS

Low-gradeSIN

1.3'/05D Class II

LSILClass II Class III

LSIL (/HSIL) Class III

High-gradeSIN

2015

NILM

HSILClass III

HSIL

Class III!Class VOQP#6$ Oinadequate)
ORP#6$ (adequate)
QP$=HF;I<E,(G2)

!

>B<NILM (negative for intraepithelial lesion or malignancy) (Class IVII-P

RP&,2)(;I<E,&-
LSIL (Low-grade squamous intraepithelial lesion or low-grade dysplasia)(*)(Class IIbVIII-)
SP:&,2)(;I<E,&-
HSIL (high-grade squamous intraepithelial lesion or high-grade dysplasia)

Normal (NILM) (Class IIIbVIV-)TP,*Class II

SCC (squamous cell carcinoma) (Class V-)
UP78O/0+C2);I<E92)A

(**)

(**)

LSILHSILSCCClass IIb+III

Class IIIb+IV(2015  "$#%&#')Class V?>@<P

INF (indefinite for neoplasm)
O2015%!"4/0CHI/05KJLMJNP$&) 74-3:&)

74

ACCB

ACB

Normal (NILM)

$!
LSIL'/,



1

%." or* %

* % or2"0ACCB

2SCC

$!
HSIL

1
#856(112"0A2015+&) 89;&).=<>?<@B/SCCCIS2132Fibroushyperplasia

Pyogenic
granuloma

epulisClass V

93Class IV

10Class III

105Class II

16211Class I

10312SCC

511HSIL

322LSIL

421NILM

1711inadequate

211

77

20

1416353 

/

CIS
1Class V

11Class IV

00Class III

52Class II

111Class I

201SCC

00HSIL

222LSIL

542NILM51149

11'$

1

dysplasia
mildoral melanosis
erosivewithstomatitis111%CIS

1Class III

32Class II

125Class I80LSIL

00NILM

41

268Class II82Class I71

NILM

42

195

lichen planus

stomatitis

2121+2$

1& #!"&% / $ %



1/

hyperkeratosis

epithelial &fibrous
hyperplasia

chronicepulis/
periodontitis papilloma/ mucositis/
inflammation1122

10*19)/Class V 1: Class III 5: Class II 11:Class I 20:HSIL 2:LSIL 5:NILM 5)(%
9$.'/11-#: 7(%
9$85.)/)Class V3HSIL.&"),!:
LSIL, NILM.21%9 ,+.)/: Class III 3:Class II 12:Class I 8
:NILM 4)(%$.'/8-#: 16:$./)Class III )(%9)class III:II:I:7/LSIL:NILM.)2:-47
 *58%8.!7!65&0779 499199 -,27*)&8!7!65&/ 0SCC 59Class V
99Class IV 19Class III 39Class II 169Class I 109HSIL
39LSIL 49NILM 18*)&
8%/ (020.$9!129!6)&
8/*09*Class V4SCC, HSIL/
'#*-"9Class III4LSIL/32&8/*09*0Class V/'#*-"9Class III, II, I*)&32&class III$II$I$"LSIL$NILM$ " !
#